Jun 29, 2025, 13:46
Molecular Upgrade: 2025 Hemophilia Care Hits Next Level
William McKeown recently posted on X:
”Beautiful slide from Maria Elisa Mancuso summarising the molecules which can be used to treat Hemophilia at the European Haemophilia Consortium Leadership Conference.”
Haemophilia management is advancing so rapidly, it’s as if the disease is preparing for early retirement!
The EHC Leadership Conference is in full swing.
From antibodies to gene therapy, Maria Elisa Mancuso took the stage to present an exciting spectrum of treatment strategies set for 2025.
More updates on Hemophilia with Hemostasis Today.
-
May 28, 2026, 13:42Claudio Laudani: Balancing Ischemic and Bleeding Risk in AF with Coronary Disease
-
May 28, 2026, 13:30When it Comes to Stroke Care, Quality Matters – Duke Health
-
May 28, 2026, 13:29Natalie Johnson: Transforming PE Care Through Endovascular Innovation
-
May 28, 2026, 13:16Francisco Chacón-Lozsán: Anticoagulation Strategies for Complex ICU Patients
-
May 28, 2026, 12:57Ahmed Kardousha: Protecting Growth and Fertility in Transfusion-Dependent β-Thalassemia
-
May 28, 2026, 12:36Kabilan K L: Key Nursing Considerations for Abciximab Therapy
-
May 28, 2026, 12:17Astha Thakkar: Practical Approaches to Platelet Thresholds in ITP
-
May 28, 2026, 09:16Maxime Dely: The Human Connection Behind Stem Cell Donation
-
May 28, 2026, 09:15Heghine Khachatryan: Maternal Health Begins With Recognizing Iron Deficiency Early